Lifetime risk of cancer reported in families with an identified mismatch repair mutation
| Colorectal cancer (men) | 28–75% |
| Colorectal cancer (women) | 24–52% |
| Endometrial cancer | 27–71% |
| Ovarian cancer | 3–13% |
| Gastric cancer | 2–13% |
| Urinary tract cancer | 1–12% |
| Brain tumour | 1–4% |
| Bile duct/gallbladder cancer | 2% |
| Small-bowel cancer | 4–7% |